Dataset: T Cell Activation in Microgravity Compared to 1g (Earth's) Gravity
This study tested the hypothesis that transcription of immediate early genes is inhibited in T cells activated in microgravity (mg)....
This study tested the hypothesis that transcription of immediate early genes is inhibited in T cells activated in microgravity (mg). Immunosuppression during spaceflight is a major barrier to safe long-term human space habitation and travel. The goals of these experiments were to prove that mg was the cause of impaired T cell activation during spaceflight as well as understand the mechanisms controlling early T cell activation. T cells from 4 human donors were stimulated with concanavalin A (ConA) and anti-CD28 onboard the International Space Station (ISS). An onboard centrifuge was used to generate a 1g simultaneous control to isolate the effects of mg from other variables of spaceflight. Microarray expression analysis after 1.5 hours of activation demonstrated that mg- and 1g-activated T cells had distinct patterns of global gene expression and identified 47 genes that were significantly differentially down-regulated in mg. Importantly, several key immediate early genes were inhibited in mg. T cells were isolated from human volunteers. T cells from each donor were kept separate and loaded into individual chambers in separate cassettes for the following treatments: mg non-activated, mg activated, and 1g activated. Therefore, samples represent biological triplicates. Experimental units were launched into space and placed into the KUBIK facility onboard the International Space Station. The 1g units were placed in the central centrifuge positions and centrifuged with an applied 1g force. The mg units were place in the static positions for continued mg exposure. After 30 minutes of pre-incubation, mg non-activated units were fixed by addition of RNALater (QIAGEN, Valencia, CA), removed from the incubator, and stored in 4°C. The mg and 1g activated units were injected with final concentration 10mg/ml Con A and 4mg/ml anti-CD28. These cassettes were replaced into KUBIK on either the centrifuge or static positions and activated for 1.5 hours. Activation was stopped with the addition of RNALater and the units were then moved to 4°C storage. All units were returned to Earth for analysis.
- Species:
- human
- Samples:
- 9
- Source:
- E-GEOD-38836
- Updated:
- Dec.12, 2014
- Registered:
- Sep.19, 2014
Sample | TREATMENT | GRAVITY |
---|---|---|
GSM950590 | Activated with 10mg/ml Con A and 4mg/ml anti-CD2 in microgravity | micro g |
GSM950590 | Activated with 10mg/ml Con A and 4mg/ml anti-CD2 in microgravity | micro g |
GSM950590 | Activated with 10mg/ml Con A and 4mg/ml anti-CD2 in microgravity | micro g |
GSM950593 | Activated with 10mg/ml Con A and 4mg/ml anti-CD2 in 1 g | 1g |
GSM950593 | Activated with 10mg/ml Con A and 4mg/ml anti-CD2 in 1 g | 1g |
GSM950593 | Activated with 10mg/ml Con A and 4mg/ml anti-CD2 in 1 g | 1g |
GSM950596 | Non-activated | micro g |
GSM950596 | Non-activated | micro g |
GSM950596 | Non-activated | micro g |